Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 3Colorectal Neoplasms 2Triple Negative Breast Neoplasms 1Sarcoma 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Inflammation 1Hot Flashes 1HER2 IHC3+ Advanced Colorectal Cancer 1Endometrial Neoplasms 1Brain Neoplasms 1

Interventions

Injections 3Doxorubicin 3anlotinib 2toripalimab 1pemigatinib 1pazopanib 1montelukast 1liposomal doxorubicin 1eribulin 1chlorhexidine gluconate 1camrelizumab 1bexmarilimab 1apatinib 1X-Rays 1Trabectedin 1Temozolomide 1Tablets 1Sodium Chloride 1Radiotherapy 1Proton Therapy 1Positron Emission Tomography Computed Tomography 1Nivolumab 1Negative-Pressure Wound Therapy 1KP 1339 1Ipilimumab 1Immunotherapy 1Heavy Ion Radiotherapy 1Granulocyte Colony-Stimulating Factor 1Epirubicin 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Sarcoma × Tablets × Clear all
NCT06887673 2025-03-20

Lipid Mediators & Cancer: Montelukast, SPM, and Almonds

University of South Florida

Phase EARLY_PHASE1 Not yet recruiting
56 enrolled
CNSGastrointestinalGynecologicSarcoma

Brain Neoplasms, Inflammation, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡